-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mental-health-mobile-apps-disposition-of-comments.pdf
May 20, 2022 - with a transparent and rigorous process with input from
stakeholders (including Federal partners: National … Other questions on
evidence are included
in Section 1C (Risk and
Mitigation Strategy). … There is also
no informed consent process to ensure that the client on the other end of the
application … of
application to the patient, the safety for phi privacy and safety away from hacking,
there is nothing … and reliability
oProvides quality requirements for health apps and defines a health app
quality
-
effectivehealthcare-admin.ahrq.gov/products/registry-of-patient-registries/research-2012
September 01, 2019 - the National Database for Autism Research (NDAR), and the National Heart, Lung and Blood Institute ( … both stakeholders and registry owners are highly recommended to help AHRQ further define requirements, priorities … registries include evaluating the safety, effectiveness, or quality of medical treatments, products, … clinical practice, effectiveness, safety, and quality. … (NIDDK) Central Data Repository, the National Database for Autism Research (NDAR), and the National
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-future-value-of-information_research.pdf
June 01, 2011 - .........................................................................................7
Search Strategy … Search Strategy and Inclusion Criteria
We searched the MEDLINE database for English-language publications … Medical Services Advisory Committee at the Australian Department of Health and
Ageing, the Australian Safety … National Institute for Health and Clinical
Excellence. … Bethesda, MD: National Cancer
Institute.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
October 01, 2015 - awaiting transplants on the national waiting list. … awaiting transplants on the national waiting list. … Patient health outcomes could be improved by the purported increase in lung tissue
quality from the … Efficacy and
safety of pirfenidone for idiopathic pulmonary
fibrosis. … Efficacy
and safety of nintedanib in idiopathic pulmonary
fibrosis.
-
effectivehealthcare-admin.ahrq.gov/products/medical-interventions-comparing/methods
December 01, 2019 - EHC
The Evidence-based Practice Centers
The Scientific Resource Center
Registry of Patient … A few examples include the National Institute for Health and Clinical Excellence (NICE) in the United … Protocol
Aug 02, 2024
Making Healthcare Safer IV: High Reliability Organization (HRO) as a Patient … Safety Practice
Research Protocol
Aug 02, 2024
Making Healthcare Safer IV: Supply … Accessibility
Disclaimers
EEO
Electronic Policies
FOIA
HHS Digital Strategy
-
effectivehealthcare-admin.ahrq.gov/products/pressure-ulcer-prevention/research-protocol
December 01, 2019 - Sample Size
Case studies with only one patient or very small numbers of patients (e.g., <20 patients … Pressure ulcers: a patient safety issue. Chapter 12 in: Hughes RG, ed. … Patient safety and quality: an evidence-based handbook for nurses. … European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel. … The impact of pressure ulcer risk assessment on patient outcomes among hospitalised patients.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
December 01, 2013 - National Institute of Mental Health (NIMH), MDD should be
treated as a separate illness for patients … might be mitigated by
poor quality of life and ongoing illness in patients with recurrent CDIs. … National Institute of Mental Health (NIMH), MDD should be treated as a
separate illness for patients … might be mitigated by poor quality of life and ongoing illness in patients with recurrent CDI. … A phase 2b, safety and
efficacy study of Boceprevir in patients
coinfected with HIV and Hepatitis
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
June 01, 2014 - a national
Healthcare Horizon Scanning System to generate information to inform comparative-effectiveness … Slowed disease progression
could lead to improved patient quality of life and reduced costs. … Patient health outcomes could be improved by the purported increase in lung
tissue quality from the … However, they called for more safety and
efficacy data, as well as long-term efficacy data, to support … Bethesda (MD): National Library of
Medicine (U.S.); 2014 May 09 [accessed 2014 Jun
16]. [4 p].
-
effectivehealthcare-admin.ahrq.gov/products/mrsa-screening-2010/research-protocol
December 01, 2019 - The Joint Commission has highlighted the issue by identifying a National Patient Safety Goal regarding … Question 5
Among ambulatory or hospitalized patients, what are the harms of a MRSA-screening strategy … Question 6
Among all ambulatory or hospitalized patients, what is the effect of a MRSA-screening strategy … Eligibility Criteria
Population(s)
The patient population is all ambulatory and hospitalized patients … Safety of patients isolated for infection control. JAMA 2003;290:1899-905.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
January 01, 2020 - Objectives
We aim to compare the effectiveness, safety and impact on quality of life of individual … The search strategy for MEDLINE can be found in
Appendix A. … For the
intermediate outcomes, safety and quality of life outcomes the timepoints of
interest are: … National Center for Health Statistics. … National Institute of Environementsl Health Sciences, National Institutes of Health.
-
effectivehealthcare-admin.ahrq.gov/products/opioids-older-adults/protocol
August 01, 2020 - Patient cognitive function, quality of life, function. … Adults: 2015 National Survey on Drug Use and Health. … The comparative safety of analgesics in older adults with arthritis. … Pharmacoepidemiology and drug safety. 2007;16(7):762-772.
29. … Accessibility
Disclaimers
EEO
Electronic Policies
FOIA
HHS Digital Strategy
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
October 01, 2011 - We
also included studies that report safety in patients with
rheumatoid arthritis or who were taking … We
did not a priori exclude studies rated poor quality, but
poor quality studies were considered to be … ), diclofenac (10/100
patient-years), and ibuprofen (11/100 patient-years). … -
years, vs. 16 to 28/1000 patient-years for the other
NSAIDs). … = histamine 2;
HR = hazard ratio; HTN = hypertension; INR = international normalized ratio; NIH = National
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_research-protocol.pdf
February 04, 2014 - published the
results of Comparative Effectiveness Review (CER) No. 20, Comparative Effectiveness
and Safety … The original proposed Key Questions (KQs) for the 2010 report entitled Comparative
Effectiveness and Safety … Interventions may occur as part of a multimodal treatment strategy if the
comparisons only differ with … Journal of the National Comprehensive
Cancer Network. 2011;9(6):665-73.
5. … Appendix A
PubMed Search Strategy
("Head and Neck Neoplasms"[Mesh]
OR
(("Neoplasms"[Mesh] OR neoplasms
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/strategies-integrating-behavioral-health-protocol.pdf
August 04, 2022 - Search Strategy. … The search for this question will require an augmented
strategy. … National Council for Mental Wellbeing. … Initial and
follow-up evaluations of integrated psychological
services for anxiety and depression in a safety … Primary
care behavioral health integration for anxiety
management in a safety-net health care system
-
effectivehealthcare-admin.ahrq.gov/products/osteoarthritis-knee-update/research-protocol
July 01, 2021 - Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health … injections and/or platelet rich plasma (inconclusive)
Off-label use for an FDA-approved product
CMS National … Cells
ACR: not mentioned
AAOS: not mentioned
Not approved by the FDA
Not covered for OA National … Not addressed for knee OA
Injected dextrose is FDA-approved for treatment of hypoglycemia only
National … with symptomatic OAK (strong)
FDA approves acupuncture needles as medical devices
CMS National
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-193-disposition-comments-naloxone.pdf
November 27, 2017 - published by the National Highway
Transportation Safety Administration in 2007. … care and
safety. … EMS
scope of practice if enhanced patient care,
assessment, and safety is demonstrated. … The lack of evidence is also reported clearly
regarding the safety of releasing opiate
overdose patients … The Future
Research Needs section is
intended to help inform
future research priorities.
-
effectivehealthcare-admin.ahrq.gov/products/phenylketonuria/research-protocol
December 01, 2019 - EHC
The Evidence-based Practice Centers
The Scientific Resource Center
Registry of Patient … of the long-term use of LNAAs and about the target patient population, including the appropriateness … Primary outcomes in a patient:
Decreasing Phe levels in the blood
Improved nutritional status … National Institutes of Health Consensus Development Panel. … Accessibility
Disclaimers
EEO
Electronic Policies
FOIA
HHS Digital Strategy
-
effectivehealthcare-admin.ahrq.gov/products/pressure-ulcer-treatment/research-protocol
December 01, 2019 - Because treatment goals for patients in hospice care differ widely from patients with pressure ulcers … relative to the number of patients enrolled, how similar those patients are to the target population … National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel. … Washington, DC: National Pressure Ulcer Advisory Panel; 2009.
Reddy M, Gill SS, Kalkar SR, et al. … Safety Practices for a New Rapid Review or Rapid Response
Page last
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
April 01, 2012 - KQ 2: For patients with PsA, do drug therapies differ
in their ability to improve patient-reported symptoms … KQ 3: For patients with PsA, do drug therapies differ in
harms, tolerability, patient adherence, or … Preventive Services Task Force (ratings: good, fair, poor)1
and the National Health Service Centre for … Safety and efficacy
of adalimumab in treatment of patients with psoriatic arthritis who
had failed … Infliximab improves
health related quality of life and physical function in patients with
psoriatic
-
effectivehealthcare-admin.ahrq.gov/products/weight-loss-surgery/research-protocol
December 01, 2019 - The benefits-to-risks ratio in the long term is also a concern: effectiveness and safety data are very … National Institutes of Health (NIH) guidelines from 1991 established the following criteria for patients … National Institutes of Health. … Medicare National Coverage Determinations Manual, Chapter 1, Part 2, Section 100.14. … Accessibility
Disclaimers
EEO
Electronic Policies
FOIA
HHS Digital Strategy